Kymera Therapeutics, Inc.

 Kymera Therapeutics, Inc. contact information is shown below
Owner:KYMERA THERAPEUTICS, INC.
Owner Address:200 Arsenal Yards Blvd., Suite 230 Watertown MA 02472
Owner Web Site
Owner Phone
Owner Toll Free
Owner Fax

 

Brands Owned byKymera Therapeutics, Inc.

Brand:

E3 HUMAN ATLAS

Description:

E THREE HUMAN ATLAS;E3;Pharmaceutical research and development; drug development and discovery services; medical and scientific research; providing medical and scientific research information in the field of pharmaceuticals;

Category: E THREE HUMAN ATLAS
Brand:

E3 LIGASE WHOLE BODY ATLAS

Description:

E THREE LIGASE WHOLE BODY ATLAS;E3 LIGASE;Pharmaceutical research and development; drug development and discovery services; medical and scientific research; providing medical and scientific research information in the field of pharmaceuticals;

Category: E THREE LIGASE WHOLE BODY
Brand:

IRAKIMID

Description:

Pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology and other related diseases; pharmaceutical and medical therapeutics for the treatment of oncology, autoimmune, immune-oncology and other related diseases; diagnostic reagents for the treatment of oncology, autoimmune, immune-oncology and other related diseases;

Category: PHARMACEUTICAL MEDICAL PREPARATIONS
Brand:

K

Description:

The mark consists of several geometric designs that form the basic elements of an animal face and the letter K forming the base of the face.;pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology and other related diseases; pharmaceutical and medical therapeutics for the treatment of oncology, autoimmune, immune-oncology and other related diseases; diagnostic reagents for the treatment of oncology, autoimmune, immune-oncology and other related diseases;Color is not claimed as a feature of the mark.;Research and development of therapeutic drugs for the treatment of oncology, autoimmune, immune-oncology and other related diseases; Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies, pharmaceuticals and biopharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Medical research for development of therapeutic modalities for treatment of diseases; Assays and reagents for use in scientific and biomedical research; Clinical studies; Preclinical and clinical development of therapeutic products;

Category: